Skip to main content

Assisted Reproduction Services

INFORMATION ON THE PROVISION AND FUNDING OF ASSISTED REPRODUCTION SERVICES

Legal Framework

Assisted reproduction services (hereinafter referred to as the Services) are provided and reimbursed in accordance with the Description of the Procedure for the Provision of Assisted Reproduction Services and Their Reimbursement from the Budget of the Compulsory Health Insurance Fund, approved by Order No. V-1452 of the Minister of Health of the Republic of Lithuania of 20 December 2016 (hereinafter referred to as the Procedure Description).

Who Is Eligible for Reimbursed Assisted Reproduction Services?

Assisted reproduction services are reimbursed from the budget of the Compulsory Health Insurance Fund (CHIF) in the following cases:

  1. The woman is aged 42 or under and the partners have been diagnosed with infertility; or
  2. Preimplantation genetic diagnosis (PGD) is required in the cases specified in the Procedure Description.

Embryo PGD is performed on the basis of a decision by a medical board consisting of a medical geneticist, an obstetrician-gynaecologist and an embryologist. The purpose is to assess the risk of transmitting a disease that causes severe disability through the reproductive cells of either partner.

PGD may be performed in the following cases:

  1. One or both partners have a hereditary disease that causes severe disability;
  2. One or both partners are carriers of a monogenic mutation;
  3. One or both partners are carriers of a chromosomal aberration;
  4. There is a risk of a spontaneous monogenic mutation and/or chromosomal aberration in the embryo.

A disease is considered to cause severe disability if it meets at least one of the following criteria:

  1. It causes severe permanent disability;
  2. It is a life-threatening health condition.

Assisted Reproduction Services Reimbursed from the CHIF Budget

The following assisted reproduction services are reimbursed from the CHIF budget:

  1. One consultation with an obstetrician-gynaecologist for a woman regarding assisted reproduction;
  2. One consultation with an obstetrician-gynaecologist for a man regarding assisted reproduction;
  3. Up to three consultations with an obstetrician-gynaecologist during controlled ovarian stimulation per treatment cycle;
  4. In vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI);
  5. Testicular sperm aspiration and processing (TESA);
  6. Intracytoplasmic sperm injection (ICSI) using oocytes stored in a gamete bank;
  7. Preparation and transfer of embryos stored in a gamete bank into the woman's uterus.

Laboratory and Diagnostic Tests

During consultations regarding assisted reproduction, the following laboratory and diagnostic tests are carried out.

For Women

Blood tests:

  • Blood group and Rh factor determination;
  • Complete blood count (CBC);
  • Coagulation tests:
    • International Normalised Ratio (INR);
    • Activated Partial Thromboplastin Time (APTT);
    • Fibrinogen;
  • Rubella IgG antibodies;
  • Hormone tests:
    • Follicle-Stimulating Hormone (FSH);
    • Luteinising Hormone (LH);
    • Estradiol (E2);
    • Prolactin (PRL);
    • Thyroid-Stimulating Hormone (TSH);
    • Anti-Müllerian Hormone (AMH).

For Men

  • Semen analysis (spermogram) performed by an embryologist.

For Both Partners

Tests for:

  • Hepatitis B surface antigen (HBsAg) and anti-HBc antibodies;
  • Hepatitis C antibodies (anti-HCV);
  • HIV type I and II antibodies (anti-HIV I/II);
  • Syphilis;
  • Sexually transmitted infections (STIs), including chlamydia, gonorrhoea and other infections.

Conditions for Receiving Reimbursed Services

A person wishing to receive CHIF-funded assisted reproduction services must:

  1. Be covered by compulsory health insurance;
  2. Apply to a healthcare institution that has a contract with the Territorial Health Insurance Fund (THIF) for the provision of these services;
  3. Have a referral from a family physician or an obstetrician-gynaecologist providing CHIF-funded services for a consultation regarding assisted reproduction.

Healthcare institutions that have concluded contracts with a THIF undertake to provide the contracted services at the base prices established by the Minister of Health.

In accordance with the Law on the Health System of the Republic of Lithuania and the Procedure for the Provision and Payment of Paid Personal Healthcare Services, approved by Order No. 357 of the Minister of Health of the Republic of Lithuania of 30 July 1999, healthcare institutions may also provide paid personal healthcare services.

Additional Payments That May Be Lawfully Charged to Insured Patients

Additional payments may be charged in the following cases:

  1. When a patient chooses more expensive services, materials or procedures on their own initiative. In this case, the patient pays the difference between the actual price and the base price;
  2. When a patient entitled to free healthcare services chooses additional services or procedures. In this case, the patient pays the full cost of those services or procedures;
  3. When a patient seeks a specialist consultation without a referral from a family physician;
  4. When a patient is referred to a specialist by a physician working in a healthcare institution that does not have a contract with the THIF;
  5. When a patient requests planned healthcare services outside the regular waiting list;
  6. When paid services included in the List of Paid Personal Healthcare Services, approved by Order No. 357, are provided.

A person is considered covered by compulsory health insurance if they pay compulsory health insurance contributions themselves, the contributions are paid on their behalf, or they are insured at the expense of the State in accordance with Article 6(4) of the Law on Health Insurance of the Republic of Lithuania.

Reimbursement of Medicines

Under Order No. V-450 of the Minister of Health of the Republic of Lithuania of 19 April 2017, amending Order No. 49 of 28 January 2000 on the Approval of Lists of Reimbursable Medicines, the following medicines were included in List A of the List of Diseases and Reimbursable Medicines:

  • Follitropin alfa;
  • Choriogonadotropin alfa.

The acquisition costs of these medicines are reimbursed from the CHIF budget at 100% of their base price.

The following medicines are also listed in relation to assisted reproduction:

  • Choriogonadotropin alfa;
  • Follitropin alfa;
  • Triptorelin;
  • Cetrorelix.

Healthcare Institutions Contracted with Territorial Health Insurance Funds for Assisted Reproduction Services

The following healthcare institutions have contracts with Territorial Health Insurance Funds for the provision of assisted reproduction services:

  • Vilnius University Hospital Santaros Klinikos;
  • Hospital of the Lithuanian University of Health Sciences Kauno Klinikos;
  • Baltic-American Clinic of Therapy and Surgery (UAB);
  • UAB Jolsana;
  • UAB Kardiolita;
  • UAB Northway Medicinos Centrai;
  • Fertility Clinic (Lithuanian-American-Israeli UAB);
  • UAB Vaisingumo centras.

Last updated: 12-11-2026